Thilo Wrede - 14 Aug 2025 Form 4 Insider Report for Vital Farms, Inc. (VITL)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Francis Cullo, Attorney-in-Fact
Issuer symbol
VITL
Transactions as of
14 Aug 2025
Net transactions value
-$61,463
Form type
4
Filing time
18 Aug 2025, 16:15:04 UTC
Previous filing
13 Aug 2025
Next filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wrede Thilo CHIEF FINANCIAL OFFICER C/O VITAL FARMS, INC., 3601 SOUTH CONGRESS AVENUE, SUITE C100, AUSTIN /s/ Francis Cullo, Attorney-in-Fact 18 Aug 2025 0001969311

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VITL Common Stock Options Exercise $99,999 +7,189 +13% $13.91 62,176 14 Aug 2025 Direct
transaction VITL Common Stock Sale $28,236 -600 -0.97% $47.06 61,576 14 Aug 2025 Direct F1, F2
transaction VITL Common Stock Sale $133,226 -2,793 -4.5% $47.70 58,783 14 Aug 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VITL Employee Stock Option (right to buy) Options Exercise $0 -7,189 -33% $0.000000 14,378 14 Aug 2025 Common Stock 7,189 $13.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.49 to $48.06 inclusive.
F4 The option vests in three equal annual installments commencing on March 17, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.